Spotlight: DNA analysis company to get $15M

 Microchip Biotechnologies says it's nearing a $15 million investment that will help it market a new machine that offers more efficient DNA analysis. Report

Suggested Articles

J&J
Biotech

J&J’s CAR-T clears multiple myeloma in 69% of patients

Janssen’s BCMA-targeting CAR-T therapy eliminated tumors in 69% of patients with advanced multiple myeloma in a small phase 1 study.

by Amirah Al Idrus
outside of building
Biotech

Bristol-Myers' CAR-T banishes lymphoma in 53% of patients

In a study, BMS' CAR-T therapy banished tumors in more than half and shrank tumors in nearly three-quarters of relapsed blood cancer patients.

by Amirah Al Idrus
Novartis
Biotech

Novartis posts more phase 3 data as EMA reviews asthma combo

Novartis unveiled more data showing how its asthma combo QMF149 fared against the standard of care: a combination of the same types of drugs.

by Amirah Al Idrus